These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6538845)

  • 1. Hypophysectomy fails to affect the supersensitivity of striatal dopamine target cells induced by prolonged haloperidol treatment.
    Scatton B; Fage D
    Eur J Pharmacol; 1984 Feb; 98(1):1-7. PubMed ID: 6538845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cyclo (Leu-Gly) on neurochemical indices of striatal dopaminergic supersensitivity induced by prolonged haloperidol treatment.
    Le Douarin C; Fage D; Scatton B
    Life Sci; 1984 Jan; 34(4):393-9. PubMed ID: 6694528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of lithium on biochemical manifestations of striatal dopamine target cell supersensitivity induced by prolonged haloperidol treatment.
    Le Douarin C; Oblin A; Fage D; Scatton B
    Eur J Pharmacol; 1983 Sep; 93(1-2):55-62. PubMed ID: 6628547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of the changes in striatal acetylcholine levels induced by pergolide and haloperidol after lesion of the nigrostriatal dopaminergic pathways in the rat.
    Fage D; Guerin B; Feuerstein C; Demenge P; Scatton B
    Brain Res; 1984 Sep; 310(2):379-83. PubMed ID: 6488029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypophysectomy may non-selectively alter pharmacokinetic parameters to enhance the ability of haloperidol to increase striatal dopamine receptor density in the rat.
    Simpson MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1986 Oct; 35(20):3501-6. PubMed ID: 3768037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium dissociates haloperidol-induced behavioral supersensitivity from reduced dopac increase in rat striatum.
    Meller E; Friedman E
    Eur J Pharmacol; 1981 Nov; 76(1):25-9. PubMed ID: 7318921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical ablation fails to influence striatal dopamine target cell supersensitivity induced by nigrostriatal denervation in the rat.
    Paturle L; Fage D; Fourrier O; Vernier P; Feuerstein C; Demenge P; Scatton B
    Brain Res; 1987 Feb; 402(2):383-6. PubMed ID: 3828803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y; Fage D; Zivkovic B; Scatton B
    J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal dopamine receptor supersensitivity after long-term haloperidol treatment of hypophysectomized rats.
    DeLucia R; Scavone C; Camillo MA
    Braz J Med Biol Res; 1989; 22(6):741-3. PubMed ID: 2620186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a stereospecific D2-dopamine agonist on acetylcholine concentration in corpus striatum of rat brain.
    Wong DT; Bymaster FP; Reid LR; Fuller RW; Perry KW; Kornfeld EC
    J Neural Transm; 1983; 58(1-2):55-67. PubMed ID: 6655467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation by pergolide of haloperidol-induced striatal dopamine receptor density.
    Koller WC
    J Clin Psychopharmacol; 1984 Dec; 4(6):343-5. PubMed ID: 6512004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the endogenous acetylcholine release from rat striatal slices.
    Alberch J; Marsal J; Solsona C
    Brain Res; 1985 Nov; 346(2):353-6. PubMed ID: 2996707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatment.
    Jenner P; Rupniak NM; Hall MD; Dyer R; Leigh N; Marsden CD
    Eur J Pharmacol; 1981 Nov; 76(1):31-6. PubMed ID: 6119220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical modulation of striatal function.
    Scatton B; Worms P; Lloyd KG; Bartholini G
    Brain Res; 1982 Jan; 232(2):331-43. PubMed ID: 6200179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypophysectomy induced hypersensitivity to dopamine: antagonism by estrogen.
    Perry KO; Diamond BI; Fields JZ; Gordon JH
    Brain Res; 1981 Dec; 226(1-2):211-9. PubMed ID: 7197571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic influences on striatal dopaminergic regulation in mice.
    Severson JA; Randall PK; Finch CE
    Brain Res; 1981 Apr; 210(1-2):201-15. PubMed ID: 6261873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
    Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
    Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of apomorphine on morphine analgesia during the state of dopaminergic supersensitivity after chronic treatment with haloperidol.
    Kamata K; Ogawa K; Noma S; Kameyama T
    J Pharmacobiodyn; 1986 Jan; 9(1):88-94. PubMed ID: 3712211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
    Commissiong JW; Slimovitch C; Toffano G
    Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment.
    Wheeler SC; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):151-9. PubMed ID: 7190650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.